{
  "id": 20167433,
  "title": "Castle Biosciences CCO Tobin W. sells $222,620 in shares",
  "url": "https://urgent.news/2026/11/15/castle-biosciences-cco-tobin-w-sells-222-620-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-15T11:31:04.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/castle-biosciences-cco-tobin-w-sells-222620-in-shares-93CH-5027849"
  },
  "original_language": "en",
  "account": "FRIENDSWOOD, TX – Castle Biosciences Inc. (CSTL) recently reported a notable insider sale by its Chief Commercial Officer, Tobin W. Juvenal. On September 14, 2026, Juvenal sold 3,306 shares of the company's common stock, valued at $222,620, at a weighted-average price of $32.324 per share. This brought his direct ownership down to 61,878 shares. The following day, he sold an additional 3,294 shares at a higher weighted-average price of $35.142, reducing his direct ownership to 58,584 shares. This sale of 6,600 shares came as Castle Biosciences' stock price surged 77% over the past six months, currently trading at $33.79 with a market capitalization of $1.04 billion. The stock is also trading near its Fair Value, according to InvestingPro analysis. The transactions were executed under a Rule 10b5-1 trading plan adopted by Juvenal on May 28, 2026. Recently, the company reported its third-quarter results, surpassing Wall Street expectations with an adjusted loss of $0.13 per share, compared to the projected $0.35 loss per share. Revenue increased by 24% to $102.9 million, exceeding the forecasted $92.41 million. These positive developments have attracted investor and analyst attention, alongside Castle Biosciences' updated full-year revenue outlook.",
  "summary": null,
  "key_points": [
    "Castle Biosciences CCO Tobin W. Juvenal sold 6,600 shares for $222,620",
    "Juvenal's direct ownership dropped to 58,584 shares after two sales",
    "Company reported Q3 loss of $0.13 per share, beating expectations"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}